Product image of Monoparin (Heparin Sodium) supplied by GNH India

Monoparin

Active Ingredient:
Heparin Sodium
Origin:
EU

Monoparin (Heparin Sodium)

Heparin Sodium, the active ingredient in Monoparin, is an anticoagulant presented as an injectable solution for intravenous use. It is employed to prevent and treat thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and to provide anticoagulation during cardiac procedures.

GNH India supplies Monoparin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to European Union quality standards and offers reliable global logistics for healthcare providers.

Manufacturer / TM Owner

Pinewood Laboratories Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Monoparin (heparin sodium) is used in clinical settings to manage conditions involving abnormal clot formation.

  • Deep vein thrombosis: prevents clot propagation and reduces risk of embolic complications.
  • Pulmonary embolism: facilitates clot dissolution and lowers recurrence risk.
  • Cardiac surgery: provides intra‑operative anticoagulation to maintain circuit patency.
  • Acute coronary syndromes: reduces thrombus growth during unstable angina or myocardial infarction.

How It Works

  • Heparin sodium binds to antithrombin III, inducing a conformational change that markedly accelerates inhibition of activated clotting factors, principally thrombin (factor IIa) and factor Xa. This potentiation impairs the conversion of fibrinogen to fibrin, thereby interrupting the coagulation cascade and preventing formation and extension of intravascular thrombi.

Side Effects

Heparin sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Bleeding at the injection site: mild bruising or hematoma.
  • Minor hemorrhage: epistaxis, gum bleeding, or easy bruising.
  • Thrombocytopenia: modest reduction in platelet count.
  • Nausea or vomiting: gastrointestinal discomfort.

Serious or Rare Side Effects

  • Heparin‑induced thrombocytopenia (HIT): immune‑mediated platelet activation leading to paradoxical clotting.
  • Major hemorrhage: life‑threatening internal bleeding, including intracranial or gastrointestinal.
  • Allergic reactions: anaphylaxis, urticaria, or severe skin rash.

Precautions & Warnings

Prior to initiating Monoparin therapy, clinicians should evaluate several safety considerations.

  • Active bleeding: avoid use in patients with ongoing hemorrhage.
  • Recent surgery or invasive procedures: assess bleeding risk before administration.
  • Renal or hepatic impairment: monitor coagulation parameters closely.
  • Concomitant antiplatelet or anticoagulant drugs: adjust dose or consider alternatives.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Heparin sodium can interact with several medications, altering anticoagulant effect or bleeding risk.

Major Interactions (Avoid)

  • Other anticoagulants (e.g., warfarin, direct oral anticoagulants): additive anticoagulation may cause severe bleeding.
  • Antiplatelet agents (aspirin, clopidogrel, ticagrelor): increase bleeding tendency.
  • Fibrinolytic therapy (tPA, streptokinase): heightened risk of hemorrhage.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): potentiate mucosal bleeding.
  • Spinal or epidural anesthesia/needle placement: risk of spinal hematoma.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: may enhance hypotensive effects when combined with heparin.
  • Corticosteroids: possible additive effect on gastrointestinal bleeding.
  • Certain antibiotics (e.g., vancomycin, quinolones): may affect platelet function.
  • Glycoprotein IIb/IIIa inhibitors: monitor for excessive bleeding.
  • Lipid‑lowering agents (statins): rare reports of increased bleeding; observe coagulation status.

Frequently Asked Questions

Monoparin contains heparin sodium and is indicated for the prevention and treatment of thromboembolic conditions such as deep vein thrombosis and pulmonary embolism, for anticoagulation during cardiac surgery, and for managing acute coronary syndromes where clot formation poses a clinical risk.

Heparin sodium binds to antithrombin III, dramatically increasing its ability to inactivate thrombin (factor IIa) and factor Xa. By blocking these key enzymes, the drug interrupts the coagulation cascade, reducing fibrin formation and preventing the growth or propagation of blood clots.

The dose of Monoparin is individualized by the prescribing clinician based on the specific indication, patient weight, renal function, and laboratory monitoring results. No fixed regimen is provided here; the prescriber determines the appropriate dosing schedule.

Safety data for heparin sodium in pregnancy and lactation are limited. It may be used during pregnancy only if the potential maternal benefit outweighs any possible risk to the fetus, and breastfeeding decisions should be made in consultation with a healthcare professional.

To order Monoparin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Monoparin (unfractionated heparin) offers rapid onset and a short half‑life, allowing quick titration, whereas low‑molecular‑weight heparins provide more predictable pharmacokinetics and once‑daily dosing but lack a readily available reversal agent. Choice depends on clinical setting, monitoring capability, and patient-specific factors.

Monoparin should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain sterility and potency.

Monoparin is administered intravenously, either as a rapid bolus injection followed by a continuous infusion or as a controlled infusion alone, depending on the clinical protocol. Administration is performed by qualified healthcare personnel in a monitored setting.

The most critical risks include major hemorrhage, especially intracranial or gastrointestinal bleeding, and heparin‑induced thrombocytopenia (HIT), an immune‑mediated reaction that can paradoxically increase clot formation. Prompt recognition and laboratory monitoring are essential.

Monoparin is contraindicated in patients with active uncontrolled bleeding, known hypersensitivity to heparin or pork products, a history of HIT, or those undergoing spinal/epidural procedures without appropriate precautions. Clinicians should also avoid use in patients with severe thrombocytopenia until the cause is clarified.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT